Antibiotics and vaccine response study
Treatments studied
Part of Immune system & allergy clinical trials.
This study looks at whether taking a short course of antibiotics changes how well vaccines work. You would receive the BCG vaccine (for tuberculosis) and possibly the yellow fever vaccine, and we would check your immune response over several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 35 years old.
- You have never had the BCG vaccine (for tuberculosis) or the yellow fever vaccine.
- You are willing to take a short course of antibiotics.
- You are willing to have up to 7 blood samples and 3 stool samples taken over 5-7 months.
- You are willing to have a small skin biopsy (only if you are in the first group).
- You are not pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your body's immune system responds to the yellow fever vaccine. It may help researchers understand how well the vaccine protects people.
This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.
This study looks at how your immune system “remembers” the yellow fever vaccine over time. It may help researchers understand long-term immune protection and how it varies between people.
This study examines special immune cells that live in your skin to understand how they work. Researchers will take small skin samples to learn more about your body's natural defenses, which could help develop better vaccines in the future.
This study tests an experimental vaccine (ID93 + GLA-SE) given alongside standard tuberculosis (TB) treatment. It aims to see if the vaccine can improve the body's response to TB treatment and reduce the chance of TB coming back.
This trial tests a new vaccine designed to help protect older adults from infections that can affect breathing. You might be able to join if you're in generally good health and meet the other requirements listed below.
Hear when a new Vaccine Response Impaired trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.